{{Rsnum
|rsid=10919563
|Gene=PTPRC
|Chromosome=1
|position=198731313
|Orientation=plus
|GMAF=0.2415
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PTPRC
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 19.5 | 80.5
| HCB | 6.6 | 43.1 | 50.4
| JPT | 4.5 | 36.6 | 58.9
| YRI | 19.0 | 48.3 | 32.7
| ASW | 10.5 | 45.6 | 43.9
| CHB | 6.6 | 43.1 | 50.4
| CHD | 3.7 | 46.8 | 49.5
| GIH | 5.0 | 22.8 | 72.3
| LWK | 29.1 | 41.8 | 29.1
| MEX | 7.0 | 35.1 | 57.9
| MKK | 4.5 | 35.3 | 60.3
| TSI | 0.0 | 21.6 | 78.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20309874
|Title=PTPRC rheumatoid arthritis risk allele is also associated with response to anti-TNF therapy
|OA=1
}}

{{PMID Auto
|PMID=19898481
|Title=Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.
|OA=1
}}

{{PMID Auto
|PMID=21952740
|Title=Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}